Proteomics $2.2M R&D rebate to fuel diagnostics test rollout The Sydney Morning Herald
Endometriosis involves oestrogen-dependent chronic inflammation and the abnormal proliferation of ectopic endometrial tissue. Conventional hormonal therapies suppress systemic oestrogen, but do not fully address local oxidative and inflammatory signalling. This …
HerAnova™ Presented at AAGL 2025, Highlighting HerResolve™ Blood Test for Non-Invasive Endometriosis Detection The National Law Review
Endometriosis-associated ovarian cancer (EAOC) mainly includes endometrioid ovarian cancer (ENOC) and clear cell ovarian cancer (CCOC). The Cancer Genome Atlas (TCGA) revealed four molecular subtypes of endometrial cancer (EC) in …
Adenomyosis is a benign displacement of endomerial tissue into the uterine myometrium, the exact pathogenesis of which has not yet been established. Recently, there has been increased research on the …
EndoDiagnosis, Inc Exhibits TIER-1 ENDOSURE Diagnostic Test for Endometriosis at AAGL 2025 in Vancouver, BC, Canada Florida Today
Endometriosis is a long-term health problem that affects a significant number of women globally. Among the various forms of endometriosis, ovarian endometriosis (OEM) is the most prevalent. This research aimed …
Proteomics International secures WA Government grant to advance world-first blood test for endometriosis BiotechDispatch
EndoDiagnosis, Inc Exhibits TIER-1 ENDOSURE Diagnostic Test for Endometriosis at AAGL 2025 in Vancouver, BC, Canada Tallahassee Democrat
Endometriosis is a chronic, estrogen-dependent disease affecting women of reproductive age. Although extragenital involvement is not uncommon, appendiceal endometriosis is a rare entity that may present with acute abdominal pain, …